Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multi-center, Non-comparative, 52-week Follow-up, Post-market Clinical Investigation of Princess® VOLUME PLUS Lidocaine in Subjects With Midface Volume Deficit

NCT03532126 is registered in ClinicalTrials.gov with Croma-Pharma GmbH as lead sponsor.

NCT NCT03532126
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03532126 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multi-center, Non-comparative, 52-week Follow-up, Post-market Clinical Investigation of Princess® VOLUME PLUS Lidocaine in Subjects With Midface Volume Deficit
Lead sponsor
Croma-Pharma GmbH
Phase
Observational
Overall status
Completed
Start date
March 28, 2018
Completion date
June 30, 2020
Enrollment
91 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

midface volume deficit